Cajal neuroscience is coming out of stealth!
I am super excited to let you know that our company Cajal neuroscience is coming out of stealth mode today! We are building the cutting edge team of scientist, engineers, business professionals and leadership team on the mission to develop new therapies agains Alzheimer's and Parkinson's diseases.
We use human genetics, human multi-omics, high-throughput microscopy and latest sequencing technologies to understand the biology of neurodegeneration and develop new drugs to help patients. I am very excited to work with the team of scientists who came from Allen Institute, University of Washington, Celgene and many other companies and universities to combine our knowledge and expertise to tackle neurodegeneration.
Check out these links below to learn more what we do.
Geekwire
Our website
Businesswire
Endpoints
Timmerman report
